BioDuro’s translational oncology services offer a comprehensive collection of validated & well-characterized in-vivo syngeneic tumor models.
Start your study today with BioDuro’s fast, dependable & communicative contract research services.
- Warm & cold tumors (CT26, MC38, 4T1, B16F10, H22, LLC)
- Small molecules, antibodies & cell-based therapies
- Each validated models is characterized with multiple standard of care immuno-oncology agents
- Uniform tumor growth; 100% engraftment overage
- Every cell prep used on study authenticated for STR & mycoplasma
- Start your study immediately; Do not wait for operational queues
- Kick of your study within 24 hours
- Expert Study Directors are extensions of your team
- Experienced scientists contribute to your study design